Sierra Legacy Group Makes New Investment in Oscar Health, Inc. $OSCR

Sierra Legacy Group bought a new stake in Oscar Health, Inc. (NYSE:OSCR) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 49,695 shares of the company’s stock, valued at approximately $941,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in OSCR. Thrive Capital Management LLC raised its holdings in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. bought a new position in shares of Oscar Health during the first quarter valued at $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Oscar Health by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after acquiring an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $16.58 on Friday. The firm’s 50-day moving average price is $15.79 and its 200-day moving average price is $16.83. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a market capitalization of $4.39 billion, a P/E ratio of -14.80 and a beta of 1.90. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same period last year, the business posted ($0.22) EPS. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently issued reports on OSCR. Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, December 6th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Zacks Research raised Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. UBS Group upgraded Oscar Health from a “sell” rating to a “neutral” rating and upped their target price for the company from $12.00 to $17.00 in a report on Friday, January 9th. Finally, Barclays set a $18.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a report on Monday, January 5th. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $17.00.

Insider Transactions at Oscar Health

In related news, insider Adam Mcananey sold 1,852 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $30,724.68. Following the transaction, the insider directly owned 179,241 shares in the company, valued at $2,973,608.19. This trade represents a 1.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the sale, the insider directly owned 350,180 shares of the company’s stock, valued at approximately $6,180,677. The trade was a 6.17% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 483,307 shares of company stock worth $7,635,300. Insiders own 24.39% of the company’s stock.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.